Skip to Content
Merck

LC/MS Analysis of Bile Acids and Their Conjugates on Ascentis® Express C18

LC/MS Analysis of Bile Acids and Their Conjugates on Ascentis® Express C18 application for HPLC

Materials

analytical column

Product No.
Description
Pricing

Ascentis® Express C18, 2.7 μm HPLC Column

2.7 μm particle size, L × I.D. 15 cm × 4.6 mm

mobile phase component

Product No.
Description
Pricing

Ammonium acetate

LiChropur, eluent additive for LC-MS

standard

Product No.
Description
Pricing

Taurocholic acid sodium salt hydrate

BioXtra, ≥95% (HPLC)

Ursodeoxycholic acid

≥99%

Cholic acid

from bovine and/or ovine, ≥98%

Lithocholic acid

≥95%

Chenodeoxycholic acid

Glycocholic acid hydrate

synthetic, ≥97% (HPLC)

CONDITIONS

sample/matrix

Plasma proteins were removed with addition of 900 μL of acetonitrile, containing deuterated internal standards, to 250 μL of human EDTA plasma. The mixture was vortexed, (centrifuged and the supermatant evaporated before being reconstituted in a 50:50 solution of methanol and water. 10 μL (corresponding to 8.57 μL of plasma) was injected into the HPLC.)

column

Ascentis Express C18, 15 cm x 4.6 mm I.D., 2.7 μm particles (53829-U)

mobile phase

[A]: Water (5 mM ammonium acetate and 0.012% formic acid); [B]: Methanol (5 mM ammonium acetate and 0.012% formic acid)

gradient

70 to 95% B in 10 minutes held 4 minutes

flow rate

0.6 mL/min

column temp.

40 °C

detector

ESI(-), MRM Mode

Description

Analysis Note

A fast robust LC-MS/MS method was developed on a C18 Ascentis Express Fused-CoreR Particle Column allowing the 15 bile acid species to be measured individually rather than the alternative measurement of a total concentration by colourimetric kinetic enzyme assays.

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany